Cassava Sciences amends bylaws to fix board size at six members

FILANA THERAPEUTICS, INC.

Board amended Article II(1) of bylaws to set board size at six directors, effective Dec 19, 2022.
Board size previously not fixed; change made by Board approval without shareholder vote.
Certificate of Amendment filed as Exhibit 3.1 to this 8-K.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

FILANA THERAPEUTICS, INC.: Amended Article II(1) of Amended and Restated Bylaws to fix board size to six members (effective 2022-12-19).

Change: bylaw amendment
Effective: 2022-12-19

Exact text from the filing

On December 19, 2022, the Board of Directors of Cassava Sciences, Inc. amended Article II(1) of its Amended and Restated Bylaws to fix the size of the board to six members, effective immediately.

View on SEC.gov

Browse all governance changes →

FILANA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001069530-22-000063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.